Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.75
(
-0.90%
)
Bitcoin
74,299.86
(
0.48%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: iwfal post# 80343

Wednesday, 07/01/2009 10:02:29 PM

Wednesday, July 01, 2009 10:02:29 PM

Post# of 257253

The point of disagreement within the scientific community isn't about CRP causation, but whether inflammation is a separate causation path potentially separately benefitted by statins. And CRP is a reliable proxy for that path.

Agreed. When viewed under this lens, the NYT article in #msg-39219495 is not one of Gina Kolata’s better efforts.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now